Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients

BACKGROUND: Switch strategies based on rilpivirine/tenofovir/emtricitabine or on an integrase inhibitor (InSTI) plus tenofovir/emtricitabine have never been compared in randomized clinical trials. The main aim of the study was to investigate the durability of these two switch regimens in virological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Gianotti, Nicola, Poli, Andrea, Nozza, Silvia, Galli, Laura, Galizzi, Nadia, Ripa, Marco, Merli, Marco, Carbone, Alessia, Spagnuolo, Vincenzo, Lazzarin, Adriano, Castagna, Antonella
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691866/
https://ncbi.nlm.nih.gov/pubmed/29145807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2831-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados